Date of Award
12-2026
Document Type
Thesis
Degree Name
Master of Science in Biology
Department
Biology
First Reader/Committee Chair
Newcomb, Laura L.
Abstract
Influenza A virus (IAV) remains a global threat to human health. Influenza is a negative sense single-stranded segmented RNA genome virus. The viral RNA dependent RNA polymerase (RdRP) lacks proofreading activity while the segmented genome can reassort with other circulating influenza viruses. This results in antigenic drift, small changes to surface antigens, and antigenic shift, the replacement of a surface antigen with that of another strain. Both antigenic drift and antigenic shift contribute to the rapid evolution of influenza viruses and emergence of novel influenza viruses with pandemic potential. Antivirals which target proteins and activities conserved among the many influenza viruses are likely to be efficacious against even emerging influenza viruses. The replication machinery of influenza is comprised of the RdRP and nucleoprotein (NP), proteins that are highly conserved across strains of IAV, and together with the genomic RNA segment, is termed viral ribonucleoprotein complex (vRNP). Essential functions and interactions among the proteins that comprise the vRNP provide multiple potential targets for disruption with antivirals. Two regions of NP were selected for this study: a region of the body domain (Bd3) and the N-terminal 20 amino acids.
Amino-acid sequence, crystal structure analysis of Nucleoprotein, and cryo-EM images of a mini-vRNP were used to identify conserved and accessible amino acids of NP within the core of the protein that may be involved in interaction with PB2. From this, 5 amino acids within a region of NP body domain were altered to glycine (Y289, K293, E294, Q308, and N309) resulting in non-functional vRNPs. Here I used sucrose gradient fractionation to confirm NPbd3 (containing all 5 glycine substitutions), is unable to bind PB2. To probe this interaction further, I used recombinant DNA plasmids to encode only 2 of the 5 glycine substitutions, NP289/293, NP293/294, NP308/309, and NP289/309. My results suggest all 5 amino acids must be altered to disrupt NP-PB2 interaction. To determine if inhibition of the defined NP-PB2 interaction is a viable antiviral target, I constructed recombinant DNA plasmid to express a peptide of the body domain 3 region of NP and found expression does inhibit influenza virus replication, suggesting the NP peptide is functioning as an inhibitor, likely binding PB2 with greater efficiency than the full NP protein. My results validate NP-PB2 interaction as a viable target for development of novel antivirals against influenza virus.
The N-terminus of NP is not present in the crystal and likely a flexible and dynamic region of the protein. The N-terminus of NP is implicated in interaction with host RNA helicase UAP56 and deletion of the N-terminal 20 amino acids reveals vRNPs with a deficiency that is exacerbated as the RNA template length is increased. To define this interaction further, I constructed recombinant DNA plasmids to encode deletions within the first 20 amino acids: NP del 14-20, NP del 2-9, NP del NcNLS (3-13). In addition, I selected highly conserved amino-acids and constructed recombinant DNA plasmids to encode specific alanine substitutions: NP S3AY10A, K7AR8A, and NP E18A. We found NP K7AR8A, NP del NcNLS (3-13), and NP del 2-9 exhibited a defect in vRNP activity while NP E18A and NP del 14-20 exhibited an increase in vRNP activity
Recommended Citation
Atkins, Cody James, "PROBING INFLUENZA NUCLEOPROTEIN FOR ANTIVIRAL TARGETS" (2026). Electronic Theses, Projects, and Dissertations. 2544.
https://scholarworks.lib.csusb.edu/etd/2544
Included in
Biochemistry Commons, Biology Commons, Influenza Humans Commons, Medical Molecular Biology Commons, Molecular Biology Commons, Nanomedicine Commons, Virology Commons, Viruses Commons